ReShape Lifesciences Inc. (RSLS)

NASDAQ: RSLS · Real-Time Price · USD

0.42

0.08 (23.89%)

At close: May 02, 2025, 3:59 PM

0.40

-5.46%

After-hours: May 02, 2025, 05:57 PM EDT

ReShape Lifesciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	693K	4.46M	3.85M	22.77M	2.96M	2.94M	5.55M	10.16M	3.31M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	2.55M	23.29M	2.5M
Long-Term Investments	n/a	n/a	n/a	-555K	-2.65M	n/a	n/a	n/a	n/a
Other Long-Term Assets	29K	29K	46K	1.46M	46K	99K	562.86K	989K	1.12M
Receivables	987K	1.66M	2.18M	2.81M	2.62M	4.1M	917K	488.61K	143.69K
Inventory	2.46M	3.74M	3.61M	3M	2.24M	1.32M	984.74K	2.82M	1.79M
Other Current Assets	114K	239K	184K	238K	209K	215K	147K	848.57K	319.00
Total Current Assets	4.59M	10.3M	9.91M	30.25M	8.94M	10.11M	8.72M	13.94M	5.72M
Property-Plant & Equipment	154K	310K	869K	1.72M	1.05M	774K	63.55K	439K	201K
Goodwill & Intangibles	n/a	n/a	260K	20.83M	27.02M	28.67M	36.93M	73.34M	n/a
Total Long-Term Assets	205K	367K	1.23M	24M	28.12M	29.55M	37.55M	74.77M	1.32M
Total Assets	4.79M	10.66M	11.14M	54.26M	37.06M	39.66M	46.27M	88.7M	7.04M
Account Payables	2.21M	1.69M	1.93M	3.47M	3.65M	4.26M	1.63M	1.09M	1.31M
Deferred Revenue	n/a	44K	510K	549K	398K	202K	352K	510K	n/a
Short-Term Debt	926K	n/a	171K	279K	3.61M	n/a	9.93M	1.96M	n/a
Other Current Liabilities	1.82M	1.17M	3.38M	1.98M	2.29M	3.3M	-6.88M	-1.01M	-2.24M
Total Current Liabilities	4.99M	3.78M	7.48M	7.33M	11.61M	10.39M	8.36M	1.09M	1.31M
Long-Term Debt	n/a	n/a	n/a	n/a	9.17M	n/a	n/a	7.96M	9.88M
Other Long-Term Liabilities	61K	72K	-123K	855K	1.64M	4.68M	6.25M	-2.67M	-9.84M
Total Long-Term Liabilities	61K	223K	2.61M	855K	10.97M	5.16M	6.25M	11.25M	2.79M
Total Liabilities	5.05M	4M	7.48M	8.19M	22.57M	15.55M	14.61M	12.34M	4.1M
Total Debt	967K	262K	171K	279K	477K	768K	6.31M	488.61K	143.69K
Common Stock	n/a	23K	1K	18K	6K	8K	87.7K	309.57K	27.37K
Retained Earnings	-642.7M	-635.57M	-624.19M	-576.76M	-514.83M	-493.2M	-418.99M	-334.76M	-300.94M
Comprehensive Income	-104K	-88K	-88K	-92K	-121K	-8K	-3.14M	-2.97M	-2.76M
Shareholders Equity	-253K	6.66M	3.66M	46.07M	14.49M	24.11M	31.66M	76.37M	2.94M
Total Investments	n/a	n/a	n/a	-555K	-2.65M	n/a	2.55M	23.29M	2.5M